Skip to main content
CHONGKUNDANG HOLDINGS CORP. logo

CHONGKUNDANG HOLDINGS CORP. — Investor Relations & Filings

Ticker · 001630 ISIN · KR7001630003 KO Professional, scientific and technical activities
Open in API
Filings indexed 425 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 001630

About CHONGKUNDANG HOLDINGS CORP.

https://www.ckd-holdings.com

Chongkundang Holdings Corp. is the holding company for the Chong Kun Dang Group, a comprehensive life care and pharmaceutical conglomerate. The company manages a diverse business portfolio through its principal subsidiaries. Chong Kun Dang Pharmaceutical develops and markets prescription drugs, over-the-counter medications, and specialized treatments. Kyongbo Pharmaceutical manufactures active pharmaceutical ingredients (APIs) and generic drugs. Chong Kun Dang Bio specializes in fermentation technology and biotechnology products, while Chong Kun Dang Health offers a wide range of health functional foods and supplements. Collectively, the group focuses on improving quality of life through innovation in pharmaceuticals, biotechnology, and healthcare solutions.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제72기) 2026년 01월 01일~2026년 03월 31일” and contains full quarterly financial statements (요약 연결/별도 재무정보, 연결 재무제표 및 주석, 별도 재무제표 및 주석), MD&A (“이사의 경영진단 및 분석의견”), audit opinions, business overview, corporate governance, and other substantive data typical of a quarterly/interim financial report. It is not a simple publication notice but the full report itself. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
투자판단관련주요경영사항(자회사의 주요경영사항) (고혈압 치료제로 개발중인 CKD339의 식약처(MFDS) 제3상 임상시험 계획 승인 신청)
Regulatory Filings Classification · 80% confidence The document is a Korean ‘투자판단 관련 주요경영사항’ announcement describing a material event (phase 3 clinical trial application approval) for investor decision — it does not present financial statements, dividend details, board changes, earnings, or fund NAV, nor is it a report publication notice or proxy statement. It is a general regulatory disclosure of a material event, fitting the fallback category Regulatory Filings (RNS).
2026-05-14 Korean
단일판매ㆍ공급계약해지(자회사의 주요경영사항)
Regulatory Filings Classification · 72% confidence The document is a notification of the termination of a single sales and supply contract by a subsidiary (경보제약) with Guangdong Landu Pharmaceutical Co., LTD. It is not a financial report, earnings release, or management discussion, nor is it a board change, share issue, or dividend notice. It is a regulatory announcement of a contract termination–a miscellaneous event that does not fit any more specific category. Therefore it falls under the general Regulatory Filings category (RNS).
2026-04-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 96% confidence The document is a Korean "주식등의 대량보유상황보고서(약식)" – a mandatory disclosure of significant shareholdings under the Capital Markets Act, showing details of the National Pension Service’s large share position in 종근당홀딩스, including share counts, ratios, and change reasons. This matches the “Major Shareholding Notification” category.
2026-04-01 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 87% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange regarding the appointment and reappointment of outside directors (사외이사) at a Korean company. This clearly falls under announcements of changes in the company’s board of directors. It is not an earnings release, dividend notice, or a link to a report, nor is it insider trading or share issuance. Therefore, it best fits the Board/Management Information category (MANG).
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the formal announcement of the resolutions and detailed voting results from the company’s 2026 annual general meeting, including vote counts and percentages for each agenda item. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.